Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSEZE
NCT02772640Phase 4Completed
- Sponsor
- Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz
- Start
- Mar 2016
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin and ezetimibe in hypercholesterolemia (2 arms), sponsored by Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz. Primary endpoints: Change in total cholesterol at 12 weeks and Change in LDL-Cholesterol at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02772640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772640.